Rubini strain-containing MMR vaccine proven its efficacy

Published: 2002-02-25 06:58:00

Updated: 2002-02-25 06:58:00

Some efficacy problems of Triviraten Berna, Rubini strain-containing MMR vaccine, have been recently raised by the Weekly Epidemiological Report of World Health Organization. It has been marketed over 15 countries in the world and Korea has imported this item. The local phase IV clinical trials i...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK